Penn Davis Mcfarland Inc Bristol Myers Squibb CO Transaction History
Penn Davis Mcfarland Inc
- $849 Million
- Q3 2024
A detailed history of Penn Davis Mcfarland Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Penn Davis Mcfarland Inc holds 357,822 shares of BMY stock, worth $20.8 Million. This represents 2.18% of its overall portfolio holdings.
Number of Shares
357,822
Previous 358,786
0.27%
Holding current value
$20.8 Million
Previous $14.9 Million
24.28%
% of portfolio
2.18%
Previous 2.42%
Shares
29 transactions
Others Institutions Holding BMY
# of Institutions
2,533Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$11 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.24 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.41 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.54 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.55 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $124B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...